Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of ASU 2016-13
After Adoption of ASU 2016-13
Common Stock
Common Stock
After Adoption of ASU 2016-13
Additional Paid-In Capital
Additional Paid-In Capital
After Adoption of ASU 2016-13
Accumulated Deficit
Accumulated Deficit
Adoption of ASU 2016-13
Accumulated Deficit
After Adoption of ASU 2016-13
Beginning Balance at Dec. 31, 2022 $ 102,624 $ (632) $ 101,992 $ 11,591 $ 11,591 $ 107,372 $ 107,372 $ (16,339) $ (632) $ (16,971)
Beginning Balance (in shares) at Dec. 31, 2022       15,973 15,973          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 641             641    
Vesting of restricted stock (181)     $ (18)   (163)        
Vesting of restricted stock (in shares)       82            
Stock-based compensation expense 509     $ 51   458        
Ending Balance at Mar. 31, 2023 102,961     $ 11,624   107,667   (16,330)    
Ending Balance (in shares) at Mar. 31, 2023       16,055            
Beginning Balance at Dec. 31, 2023 $ 78,971     $ 11,729   108,615   (41,373)    
Beginning Balance (in shares) at Dec. 31, 2023 16,258     16,258            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income $ 6,240             6,240    
Stock-based compensation expense 506     $ 50   456        
Repurchases of common stock (273)     $ (27)   (246)        
Repurchases of common stock (in shares)       (61)            
Ending Balance at Mar. 31, 2024 $ 85,444     $ 11,752   $ 108,825   $ (35,133)    
Ending Balance (in shares) at Mar. 31, 2024 16,197     16,197